| 2024/06/27 17:35:01 | |
|---|---|
| Price | |
| 6.58 EUR | |
| Difference | -7.06% (-0.50) |
General attributes
| ISIN | BE0974358906 |
| Symbol | NYXH |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 221 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | 6.44 EUR (1,500) |
| Ask (Ask size) | 6.86 EUR (330) |
| Open | 6.70 EUR |
| High | 6.90 EUR |
| Low | 6.26 EUR |
| Close (prev. day) | 7.08 EUR |
| VWAP | 6.589379 EUR |
| Volume (pcs) | 56,491 |
| Trading volume | 372,241.00 |
| Number of trades | 268 |
| Last size | 5 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: NYXOAH SA NPV |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/06/27 17:35:01 | |
|---|---|
| Price | |
| 6.58 EUR | |
| Difference | -7.06% (-0.50) |
General attributes
| ISIN | BE0974358906 |
| Symbol | NYXH |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 221 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | 6.44 EUR (1,500) |
| Ask (Ask size) | 6.86 EUR (330) |
| Open | 6.70 EUR |
| High | 6.90 EUR |
| Low | 6.26 EUR |
| Close (prev. day) | 7.08 EUR |
| VWAP | 6.589379 EUR |
| Volume (pcs) | 56,491 |
| Trading volume | 372,241.00 |
| Number of trades | 268 |
| Last size | 5 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +52.31% | -8.61% | -73.52% |
| Perf (abs.) | +2.26 | -0.62 | -18.27 |
| Beta | 1.67 | 0.77 | 0.60 |
| Volatility | 131.25 | 97.49 | 70.07 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 7.31 EUR (52,189) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 8.14 EUR (39,032) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 10.51 EUR (46,105) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 7.87 EUR (31,079) |
| YTD High | date | 17.60 EUR (2024/03/19) |
| YTD Low | date | 3.79 EUR (2024/01/19) |
| 52 Weeks High | date | 17.60 EUR (2024/03/19) |
| 52 Weeks Low | date | 3.79 EUR (2024/01/19) |
All listings for NYXOAH SA NPV
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Stuttgart | 2024/06/27 | 13:28 | 6.52 EUR | 0.00 | 3 |
| Nasdaq | 2024/06/27 | 20:32 | 6.96 USD | 0.07 | 82 |
| Munich | 2024/06/27 | 08:06 | 7.38 EUR | 0.00 | 1 |
| Frankfurt | 2024/06/27 | 15:29 | 6.22 EUR | 0.00 | 4 |
| Euronext Brussels | 2024/06/27 | 17:35 | 6.58 EUR | 0.37 | 268 |
| Duesseldorf | 2024/06/27 | 08:12 | 6.68 EUR | 0.00 | 1 |
Company Logo
Contact Details
| NYXOAH SA |
| - - |
| Rue Edouard Belin 12 - 1435 Mont-Saint-Guibert |
| Telefon: +32-10-22-23-55 |
| Fax: + |
| E-mail: info@nyxoah.com |
PDF Downloads
| Company report: NYXOAH SA NPV | |
Company Profile
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium. |
Members of Management Board
| Olivier Taelman | Chairman of Managing Board |
| An Moonen | Member of Executive Committee |
| Bruno Onkelinx | Member of Executive Committee |
| Chris Eigenmann | Member of Executive Committee |
| David DeMartino | Member of Executive Committee |
| Loic Moreau | Member of Executive Committee |
Board of directors
| Robert Taub | Chairman of Supervisory Board |
| Jürgen Hambrecht | Member of Supervisory Board |
| Pierre Gianello | Member of Supervisory Board |
| Daniel Wildman | Member of Supervisory Board |
| Kevin Rakin | Member of Supervisory Board |
| Rita Johnson-Mills | Member of Supervisory Board |
| Virginia Kirby | Member of Supervisory Board |